Practice
Featured experience
Incora emerges from chapter 11
We advised an ad hoc group of secured noteholders in connection with Incora’s chapter 11 proceedings
Venture Global $1.75 billion IPO
We advised Venture Global on its IPO and NYSE listing
Interactive Brokers claims for domestic production activities deductions
We are representing Interactive Brokers
Advice to multiple companies on potential tax refunds under the Varian ruling
We are representing clients in refund claims
Tenaya Therapeutics $50 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Select Market
Gilead Sciences $4.3 billion acquisition of CymaBay Therapeutics
We are advising Gilead Sciences on the acquisition
Eli Lilly $6.5 billion notes offering
The investment-grade notes are due 2027, 2029, 2034, 2054 and 2064
Deutsche Bank $1 billion notes offering
The fixed-to-floating-rate eligible liabilities notes are due 2028
Air Products and Chemicals $2.5 billion green notes offering
The investment-grade notes are due 2029, 2031 and 2034
Texas Instruments $3 billion notes offering
We advised Texas Instruments on its investment-grade debt offering
Owens Corning $3.9 billion acquisition of Masonite International
We are advising Owens Corning on the acquisition
Morgan Stanley $1.5 billion subordinated reset notes offering
We advised Morgan Stanley on its SEC-registered global offering
Azul $148.7 million secured notes reopening
The senior secured notes are due 2028
MSCI acquisition of Foxberry
We are advising MSCI on the acquisition